D.A. Davidson & Co. Intra Cellular Therapies, Inc. Transaction History

D.A. Davidson & Co.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 29, 2019	SELL	$10.36 - $20.96 $96,327 - $194,886	-9,298 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$17.77 - $22.9 $145,269 - $187,207	-8,175 Reduced 46.79%	9,298 $202,000
Q2 2018 Aug 02, 2018	BUY	$17.33 - $23.4 $3,743 - $5,054	216 Added 1.25%	17,473 $309,000
Q1 2018 May 04, 2018	BUY	$15.16 - $25.49 $261,616 - $439,880	17,257 New	17,257 $363,000

378

84.1M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.86B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

Stay updated on D.A. Davidson & Co. with notifications on news.